ID   AG10B_HUMAN             Reviewed;         473 AA.
AC   Q5I7T1; B2RPF4;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   18-JUN-2025, entry version 150.
DE   RecName: Full=Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase {ECO:0000305|PubMed:14525949};
DE            EC=2.4.1.256 {ECO:0000269|PubMed:20950623};
DE   AltName: Full=Alpha-1,2-glucosyltransferase ALG10-A;
DE   AltName: Full=Alpha-2-glucosyltransferase ALG10-B;
DE   AltName: Full=Asparagine-linked glycosylation protein 10 homolog B {ECO:0000312|HGNC:HGNC:31088};
DE   AltName: Full=Potassium channel regulator 1 {ECO:0000303|PubMed:14525949};
GN   Name=ALG10B {ECO:0000312|HGNC:HGNC:31088};
GN   Synonyms=KCR1 {ECO:0000303|PubMed:14525949};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT GLY-84.
RX   PubMed=14525949; DOI=10.1096/fj.02-1057fje;
RA   Kupershmidt S., Yang I.C.-H., Hayashi K., Wei J., Chanthaphaychith S.,
RA   Petersen C.I., Johns D.C., George A.L. Jr., Roden D.M., Balser J.R.;
RT   "The IKr drug response is modulated by KCR1 in transfected cardiac and
RT   noncardiac cell lines.";
RL   FASEB J. 17:2263-2265(2003).
RN   [2]
RP   SEQUENCE REVISION.
RA   George A.L. Jr.;
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLY-84.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-84.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANT VAL-446.
RX   PubMed=15280551; DOI=10.1073/pnas.0306005101;
RA   Petersen C.I., McFarland T.R., Stepanovic S.Z., Yang P., Reiner D.J.,
RA   Hayashi K., George A.L. Jr., Roden D.M., Thomas J.H., Balser J.R.;
RT   "In vivo identification of genes that modify ether-a-go-go-related gene
RT   activity in Caenorhabditis elegans may also affect human cardiac
RT   arrhythmia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:11773-11778(2004).
RN   [7]
RP   VARIANT ASP-33, CHARACTERIZATION OF VARIANT ASP-33, FUNCTION, CATALYTIC
RP   ACTIVITY, PATHWAY, AND SUBCELLULAR LOCATION.
RX   PubMed=20950623; DOI=10.1016/j.yjmcc.2010.10.007;
RA   Hayashi K., Fujino N., Ino H., Uchiyama K., Sakata K., Konno T., Masuta E.,
RA   Funada A., Sakamoto Y., Tsubokawa T., Hodatsu A., Yasuda T., Kanaya H.,
RA   Kim M.Y., Kupershmidt S., Higashida H., Yamagishi M.;
RT   "A KCR1 variant implicated in susceptibility to the long QT syndrome.";
RL   J. Mol. Cell. Cardiol. 50:50-57(2011).
CC   -!- FUNCTION: Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-
CC       glucosyltransferase that operates in the biosynthetic pathway of
CC       dolichol-linked oligosaccharides, the glycan precursors employed in
CC       protein asparagine (N)-glycosylation. The assembly of dolichol-linked
CC       oligosaccharides begins on the cytosolic side of the endoplasmic
CC       reticulum membrane and finishes in its lumen. The sequential addition
CC       of sugars to dolichol pyrophosphate produces dolichol-linked
CC       oligosaccharides containing fourteen sugars, including two GlcNAcs,
CC       nine mannoses and three glucoses. Once assembled, the oligosaccharide
CC       is transferred from the lipid to nascent proteins by
CC       oligosaccharyltransferases. In the lumen of the endoplasmic reticulum,
CC       adds the third and last glucose residue from dolichyl phosphate glucose
CC       (Dol-P-Glc) onto the lipid-linked oligosaccharide intermediate
CC       Glc(2)Man(9)GlcNAc(2)-PP-Dol to produce Glc(3)Man(9)GlcNAc(2)-PP-Dol.
CC       {ECO:0000269|PubMed:20950623}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an alpha-D-Glc-(1->3)-alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-
CC         alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-
CC         Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-
CC         (1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-
CC         diphospho-di-trans,poly-cis-dolichol + a di-trans,poly-cis-dolichyl
CC         beta-D-glucosyl phosphate = a alpha-D-Glc-(1->2)-alpha-D-Glc-(1->3)-
CC         alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-
CC         (1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-
CC         alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-
CC         GlcNAc-(1->4)-alpha-D-GlcNAc-diphospho-di-trans,poly-cis-dolichol + a
CC         di-trans,poly-cis-dolichyl phosphate + H(+); Xref=Rhea:RHEA:29543,
CC         Rhea:RHEA-COMP:19498, Rhea:RHEA-COMP:19502, Rhea:RHEA-COMP:19512,
CC         Rhea:RHEA-COMP:19522, ChEBI:CHEBI:15378, ChEBI:CHEBI:57525,
CC         ChEBI:CHEBI:57683, ChEBI:CHEBI:132522, ChEBI:CHEBI:132523;
CC         EC=2.4.1.256; Evidence={ECO:0000269|PubMed:20950623};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:29544;
CC         Evidence={ECO:0000269|PubMed:20950623};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:20950623}.
CC   -!- SUBUNIT: Interacts with KCNH1; may regulate KCNH1, possibly by
CC       regulating its N-glycosylation. Interacts with KCNH2; may reduce KCNH2
CC       sensitivity to classic proarrhythmic drug blockade, possibly by
CC       regulating its N-glycosylation. {ECO:0000250|UniProtKB:O88788}.
CC   -!- INTERACTION:
CC       Q5I7T1; P11912: CD79A; NbExp=3; IntAct=EBI-18075734, EBI-7797864;
CC       Q5I7T1; Q3SXP7: SHISAL1; NbExp=3; IntAct=EBI-18075734, EBI-18037857;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:20950623}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Also detected at the plasma membrane.
CC       {ECO:0000250|UniProtKB:O88788}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, placenta, liver, kidney
CC       and pancreas. Weakly expressed in lung, skeletal muscle and brain.
CC       {ECO:0000269|PubMed:14525949}.
CC   -!- SIMILARITY: Belongs to the ALG10 glucosyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY845858; AAW31756.1; -; mRNA.
DR   EMBL; AC117372; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW57795.1; -; Genomic_DNA.
DR   EMBL; BC137413; AAI37414.1; -; mRNA.
DR   EMBL; BC137414; AAI37415.1; -; mRNA.
DR   CCDS; CCDS31772.1; -.
DR   RefSeq; NP_001013642.2; NM_001013620.4.
DR   AlphaFoldDB; Q5I7T1; -.
DR   BioGRID; 126840; 48.
DR   FunCoup; Q5I7T1; 2237.
DR   IntAct; Q5I7T1; 7.
DR   STRING; 9606.ENSP00000310120; -.
DR   GlyGen; Q5I7T1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q5I7T1; -.
DR   PhosphoSitePlus; Q5I7T1; -.
DR   SwissPalm; Q5I7T1; -.
DR   BioMuta; ALG10B; -.
DR   DMDM; 296434391; -.
DR   jPOST; Q5I7T1; -.
DR   MassIVE; Q5I7T1; -.
DR   PaxDb; 9606-ENSP00000310120; -.
DR   PeptideAtlas; Q5I7T1; -.
DR   ProteomicsDB; 62974; -.
DR   Pumba; Q5I7T1; -.
DR   Antibodypedia; 55463; 74 antibodies from 13 providers.
DR   DNASU; 144245; -.
DR   Ensembl; ENST00000308742.9; ENSP00000310120.4; ENSG00000175548.9.
DR   GeneID; 144245; -.
DR   KEGG; hsa:144245; -.
DR   MANE-Select; ENST00000308742.9; ENSP00000310120.4; NM_001013620.4; NP_001013642.2.
DR   UCSC; uc001rln.5; human.
DR   AGR; HGNC:31088; -.
DR   CTD; 144245; -.
DR   DisGeNET; 144245; -.
DR   GeneCards; ALG10B; -.
DR   HGNC; HGNC:31088; ALG10B.
DR   HPA; ENSG00000175548; Low tissue specificity.
DR   MalaCards; ALG10B; -.
DR   MIM; 603313; gene.
DR   OpenTargets; ENSG00000175548; -.
DR   VEuPathDB; HostDB:ENSG00000175548; -.
DR   eggNOG; KOG2642; Eukaryota.
DR   GeneTree; ENSGT00390000012906; -.
DR   HOGENOM; CLU_017053_1_0_1; -.
DR   InParanoid; Q5I7T1; -.
DR   OMA; FPINWNT; -.
DR   OrthoDB; 4769at2759; -.
DR   PAN-GO; Q5I7T1; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q5I7T1; -.
DR   PathwayCommons; Q5I7T1; -.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   SignaLink; Q5I7T1; -.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 144245; 116 hits in 1082 CRISPR screens.
DR   ChiTaRS; ALG10B; human.
DR   GenomeRNAi; 144245; -.
DR   Pharos; Q5I7T1; Tbio.
DR   PRO; PR:Q5I7T1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q5I7T1; protein.
DR   Bgee; ENSG00000175548; Expressed in calcaneal tendon and 159 other cell types or tissues.
DR   ExpressionAtlas; Q5I7T1; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IGI:UniProtKB.
DR   GO; GO:0098553; C:lumenal side of endoplasmic reticulum membrane; IC:UniProt.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0106073; F:dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity; IGI:UniProtKB.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; IGI:UniProtKB.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IGI:UniProtKB.
DR   InterPro; IPR016900; Alg10.
DR   PANTHER; PTHR12989; ALPHA-1,2-GLUCOSYLTRANSFERASE ALG10; 1.
DR   PANTHER; PTHR12989:SF12; DOL-P-GLC:GLC(2)MAN(9)GLCNAC(2)-PP-DOL ALPHA-1,2-GLUCOSYLTRANSFERASE-RELATED; 1.
DR   Pfam; PF04922; DIE2_ALG10; 1.
DR   PIRSF; PIRSF028810; Alpha1_2_glucosyltferase_Alg10; 1.
DR   neXtProt; NX_Q5I7T1; -.
DR   PharmGKB; PA134936082; -.
DR   TreeFam; TF300150; -.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Glycosyltransferase; Membrane; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..473
FT                   /note="Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-
FT                   glucosyltransferase"
FT                   /id="PRO_0000215448"
FT   TOPO_DOM        1..6
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        7..27
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        28..64
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        65..85
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        86..97
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        98..118
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        119..126
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        127..147
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        148..150
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        151..171
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        172..175
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        176..196
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        197..256
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        257..277
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        278..283
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        284..304
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        305..317
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        318..338
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        339..365
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        366..386
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        387..392
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        393..413
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        414..436
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        437..457
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        458..473
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   VARIANT         33
FT                   /note="E -> D (found in a patient with ventricular
FT                   fibrillation and QT prolongation; uncertain significance;
FT                   dbSNP:rs188043534)"
FT                   /evidence="ECO:0000269|PubMed:20950623"
FT                   /id="VAR_089086"
FT   VARIANT         84
FT                   /note="A -> G (in dbSNP:rs6582584)"
FT                   /evidence="ECO:0000269|PubMed:14525949,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.4"
FT                   /id="VAR_048217"
FT   VARIANT         383
FT                   /note="S -> N (in dbSNP:rs57963306)"
FT                   /id="VAR_061002"
FT   VARIANT         446
FT                   /note="I -> V (in dbSNP:rs61730283)"
FT                   /evidence="ECO:0000269|PubMed:15280551"
FT                   /id="VAR_023753"
SQ   SEQUENCE   473 AA;  55448 MW;  47D0CF7B6C84B8EC CRC64;
     MAQLEGYCFS AALSCTFLVS CLLFSAFSRA LREPYMDEIF HLPQAQRYCE GHFSLSQWDP
     MITTLPGLYL VSVGVVKPAI WIFAWSEHVV CSIGMLRFVN LLFSVGNFYL LYLLFHKVQP
     RNKAASSIQR VLSTLTLAVF PTLYFFNFLY YTEAGSMFFT LFAYLMCLYG NHKTSAFLGF
     CGFMFRQTNI IWAVFCAGNV IAQKLTEAWK TELQKKEDRL PPIKGPFAEF RKILQFLLAY
     SMSFKNLSML FCLTWPYILL GFLFCAFVVV NGGIVIGDRS SHEACLHFPQ LFYFFSFTLF
     FSFPHLLSPS KIKTFLSLVW KHGILFLVVT LVSVFLVWKF TYAHKYLLAD NRHYTFYVWK
     RVFQRYAILK YLLVPAYIFA GWSIADSLKS KPIFWNLMFF ICLFIVIVPQ KLLEFRYFIL
     PYVIYRLNIT LPPTSRLVCE LSCYAIVNFI TFYIFLNKTF QWPNSQDIQR FMW
//
https://api.ncbi.nlm.nih.gov/datasets/v2/gene/id/144245/download?include_annotation_type=FASTA_RNA&include_annotation_type=FASTA_PROTEIN&aux_report=PRODUCT_REPORT
